Objective: To assess the safety and efficacy of an early enteral pharmaconutrition supplement containing glutamine dipeptides, antioxidative vitamins and trace elements, and butyrate in critically ill, septic patients.
Design: A prospective, randomized, controlled, double-blind clinical trial.
Setting: Adult intensive care unit in a university hospital.